• News Archive
  • Simaster
  • Webmail
  • Directory
  • Crisis Center
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • Doctoral dissertation
  • Patients of Breast Cancer is Increasing

Patients of Breast Cancer is Increasing

  • 14 September 2016, 09:23 WIB
  • By: Marwati
  • 2200
Jumlah Pasien Terdiagnosis Kanker Payudara Terus Meningkat

Breast cancer is the main health issue for women all over the world. The prevalence of the disease in the past decade has increased globally. Data from International Agency for Research on Cancer (IARC) GLOBOCAN year 2012 recorded as many as 1.7 million of women are diagnosed with breast cancer, which was 11.9 percent of all cancer incidences. The WHO showed the breast cancer prevalence was 6.3 million by the end of 2012, spreading in 140 nations. Brest cancer HER2 positive was reported to reach 15-20 percent  of all breast cancer in the world. In Indonesia, the figure is estimated at 10-30 percent and is found in women aged 10 years younger than those of Caucasoid.

dr.Woro Rukmi Pratiwi , M. Kes., Sp.PD., Pharmacology and Therapy lecturer at Faculty of Medicine UGM, said the breast cancer HER2 positive corresponds with poor therapy results. Presently, therapies using monoclonal anti HER2 therapy give better prognosis for patients of breast cancer HER2 positive.

“Some therapy approaches have been developed rapidly, including on the use of new regiment such as adjuvant and target therapies,” she said on Tuesday (13/9) at Faculty of Medicine UGM.

Defending her dissertation entitled “Disease Free Survival, Quality of Life and Direct Medical Post Breast Cancer HER2 Positive Early Stadium That Undergo Chemotherapy Adjuvant Anti Her2 in Dr. Sardjito General Hospital Years 2007-2014, Woro said such approaches have diverse effects. Therapy outcomes in early stadium of breast cancer are among others, Disease Free Survival (DFS) and quality of life. Despite the administration of HER2 positive of early stadium uses anti HER2 effective, but comprehensive administration that includes surgery, chemotherapy, and radiotherapy are still applied to have better therapy outcomes.

Woro’s research in 100 patients of breast cancer HER2 positive in early stadium that receive anti-HER2 therapy in Dr. Sardjito Hospital resulted that the type of chemotherapy regiment based on taxan and chemoterapy intervals with radiotherapy less or same with 300 days will affect the therapy outcome for HER2 positive of early stadium. Intervals of  radiotherapy with chemotherapy that is longer will increase the risk for disease deterioriation. Costs will increase, too.

“So, a scheduling is important for the intervals of radiotherapy with chemotherapy that is shorter, or less than 210 days to improve therapy outcomes, as well as to reduce costs,” she concluded.

Related News

  • The Importance of Volunteer Assistance for Cancer Patients

    Thursday,17 May 2018 - 13:53
  • UGM Students Make Bras for People Having Breast Surgery

    Thursday,02 June 2016 - 8:20
  • Patients of Breast Cancer is Increasing

    Wednesday,14 September 2016 - 9:23
  • Calculations on Breast Cancer Risk Factor Is Necessary

    Tuesday,29 September 2020 - 15:33
  • UGM to Collect Cancer Genomic Data in Indonesia

    Tuesday,17 January 2017 - 9:06

News Releases

  • Biology Students Grab 2 Prizes in Indonesia-Wide Scientific Writing Competition 26 May 2023
    A team from the UGM Faculty of Biology has won two
    Salma
  • Professor Ika Dewi Ana Receives WIPO National Award for Inventors 22 May 2023
    Professor Ika Dewi Ana from the UGM Faculty of Den
    Salma
  • Civil Engineering Students Win International BIM Innovation Contest CEIC XI 22 May 2023
    Three UGM Civil Engineering students, teaming up a
    Salma
  • UGM Student Represents R&D Company Stechoq at 2023 Hannover Messe 19 May 2023
    Mahesa Audriansyah Agatha, a Department of Mechani
    Salma
  • Social Development and Welfare & Save The Children Indonesia Discuss Parenting in Indonesia 19 May 2023
    The UGM Department of Social Development and Welfa
    Salma

Event

  • 06Sep The 5th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC) 2023...
  • 02Oct Conference of Critical Island Studies...
  • 04Oct The 7th Astechnova International Energy Conference...
Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2023 Universitas Gadjah Mada

PRIVACY POLICYCONTACT